Cancer Detection and Diagnosis Research in Ohio
Cancer Detection and Diagnosis Research (93.394) awarded $98.1 million to recipients in Ohio in 56 grants from fiscal 2021 to 2025, 3.6% of the program's national total. Research Institute at Nationwide Children's Hospital received the most, $42.2 million.
- Awarded in Ohio$98.1 million
- Awards56
- Share of the program3.6%
- Rank among states8th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 30 | $17.5 million |
| FY 2022 | 21 | $14.8 million |
| FY 2023 | 27 | $22.8 million |
| FY 2024 | 29 | $20.3 million |
| FY 2025 | 27 | $22.8 million |
Recipients in Ohio
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Research Institute at Nationwide Children's Hospital | Nonprofits | 4 | $42.2 million |
| Case Western Reserve University | Colleges and universities | 21 | $24.6 million |
| The Ohio State University | Colleges and universities | 14 | $14.7 million |
| Cleveland Clinic Lerner College of Medicine of Case Western Reserve University | Colleges and universities | 4 | $5.2 million |
| Molecular Theranostics LLC | Small businesses | 1 | $2.0 million |
| GLC Biotechnology Inc | Small businesses | 1 | $2.0 million |
| Cincinnati Univ of | Colleges and universities | 2 | $1.7 million |
| Am Operating LLC | Small businesses | 2 | $1.5 million |
| University of Toledo | Colleges and universities | 1 | $1.5 million |
| Integrated Sensors, LLC | Small businesses | 1 | $561,573 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Ohio?
$98.1 million from fiscal 2021 to 2025, across 56 awards. Ohio ranks 8th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Ohio?
The largest recipient is Research Institute at Nationwide Children's Hospital, with $42.2 million in 4 awards. Next are Case Western Reserve University and The Ohio State University.
Can organizations in Ohio apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Ohio
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Title I Grants to Local Educational Agencies
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Head Start